Heather White
Direttore Tecnico/Scientifico/R&S presso ALBIREO PHARMA, INC.
Posizioni attive di Heather White
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 02/03/2023 | - |
Storia della carriera di Heather White
Precedenti posizioni note di Heather White
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AMICUS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2008 | - |
Schering-Plough Ltd.
 Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 | - |
| IPSEN | Comptroller/Controller/Auditor | 01/01/2014 | - |
Formazione di Heather White
| The University of Liverpool | Graduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Stati Uniti | 3 |
| Francia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IPSEN | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Schering-Plough Ltd.
Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Heather White
- Esperienza